[1] 陈万青, 郑荣寿, 张思维, 等.2013年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2017, 26(1):1-7.
[2] MARIETTE C, MARKAR S R, DABAKUYO-YONLI T S, et al. Hybrid minimally invasive esophagectomy for esophageal cancer[J]. N Engl J Med, 2019, 380(2):152-162.
[3] SHAPIRO J, VANLANSCHOT J J B, HULSHOF M C C M, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer(CROSS):long-term results of a randomised controlled trial[J]. Lancet Oncol, 2015, 16(9):1090-1098.
[4] 袁勇, 陈龙奇.AJCC第八版食管癌分期系统更新解读[J]. 中华外科杂志, 2017, 55(2):109-113.
[5] 许淑华, 何祺煜, 王小军, 等.胸腔镜食管癌术后常见并发症的比较分析[J]. 东南大学学报(医学版), 2021, 40(1):74-77.
[6] AJANI J A, DAMICO T A, BENTREM D J, et al. Esophageal and 40 esophagogastric junction cancers, Version 2.2019, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Cancer Netw, 2019, 17(7):855-883.
[7] YANG H, LIU H, CHEN Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cellcarcinoma of the esophagus:the(NEOCRTEC5010):a phase Ⅲ multicenter, randomized, open-label clinical trial[J]. J Clin Oncol, 2018, 36(27):2796-2803.
[8] 续文栋, 金澄宇, 杜亮, 等.微创食管癌手术的研究进展[J]. 中国临床研究, 2018, 31(5):688-690.
[9] 徐伟, 尹哲, 蔡华荣, 等.腔镜辅助经颈-腹-纵隔食管癌根治术治疗胸段食管癌30例[J]. 中国微创外科杂志, 2018, 18(2):104-106.
[10] SDRALIS E, DAVAKIS S, SYLLAIOS A, et al. Minimally invasive esophagectomy for esophageal cancer in octogenarians.Clinical and oncological outcomes[J]. J BUON, 2020, 25(1):520-526.
[11] MIURA S, NAKAMURA T, MIURA Y, et al. Long-term outcomes of thoracoscopic esophagectomy in the prone versus lateral position:a propensity score-matched analysis[J]. Ann Surg Oncol, 2019, 26:3736-3744.
[12] MIURA S, KAKEJI Y.ASO author reflections:minimally invasive esophagectomy for esophageal cancer in the prone and lateral position[J]. Ann Surg Oncol, 2019, 26(Suppl 3):817.
[13] KUWABARA S, KOBAYASHI K, KUBOTA A, et al. Comparison of perioperative and oncological outcome of thoracoscopic esophagectomy in left decubitus position and in prone position for esophageal cancer[J]. Langenbecks Arch Surg, 2018, 403:607-614.
[14] JARRAL O A, PURKAYASTHA S, ATHANASIOU T, et al. Should thoracoscopic three-stage esophagectomy be performed in the prone or left lateral decubitus position?[J]. Interact Cardiovasc Thorac Surg, 2011, 13(1):60-65.
[15] SEESING M F J, GOENSE L, RUURDA J P, et al. Minimally invasive esophagectomy:a propensity score-matched analysis of semiprone versus prone position[J]. Surg Endosc, 2018, 32:2758-2765.
[16] 陈椿.微创食管癌切除术——福建医科大学之经验[J]. 临床外科杂志, 2016, 24(7):560-561.
[17] WANG Q, WU Z X, ZHAN T W, et al. Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients:a propensity score-matched analysis[J]. BMC Cancer, 2019, 19(1):500.
[18] 林涛, 解明然, 马冬春.微创与开放Ivor Lewis食管切除术后急慢性疼痛对比研究[J]. 中华肿瘤防治杂志, 2019, 26(11):784-789.
[19] STRAAMAN J, VANDER W N, NIEUWENHUIJZEN G A, et al. Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers:pooled data from six European centers[J]. Surg Endosc, 2017, 31(1):119-126.
[20] WORKUM F, MAAS J, WILDENBERG F J, et al. Improved functional results after minimally invasive esophagectomy:intrathoracic versus cervical anastomosis[J]. Ann Surg Oncol, 2017, 103(1):267-273.
[21] SHANMUGASUNDARAM R, HOPKINS R, NEEMAN T, et al. Minimally invasive McKeown's vs open esophagectomy for cancer:a meta-analysis[J]. Eur J Surg Oncol, 2019, 45(6):941-949.
[22] DENG J, SU Q, REN Z, et al. Comparison of short-term outcomes between minimally invasive McKeown and Ivor Lewis esophagectomy for esophageal or junctional cancer:a systematic review and meta-analysis[J]. Onco Targets Ther, 2018, 11:6057-6069.
[23] BROWN A M, PUCCI M J, BERGER A C, et al. A standardized comparison of perioperative complications after minimally invasive esophagectomy:Ivor Lewis versus McKeown[J]. Surg Endosc, 2018, 32(1):204-211.
[24] 朱小东, 吴汉然, 徐广文, 等.倾向评分匹配后微创Ivor Lewis术与微创McKeown术治疗中下段食管鳞癌的近、远期疗效比较[J]. 中华胸心血管外科杂志, 2020, 36(2):98-103.
[25] GILLINOV A M, HEITMILLER R F.Strategies to reduce pulmonarycomplications after transhiatal esophagectomy[J]. Dis Esophagus, 2017, 11(1):43-47.
[26] 刘庆文, 武强, 唐桂旺, 等.纵隔镜在食管癌根治术中的研究进展[J]. 中国胸心血管外科临床杂志, 2019(7):728-733.
[27] 曹庆东, 钟北龙, 李晓剑, 等.单孔充气式纵隔镜同步腹腔镜食管癌根治术初步探索[J]. 中华胸心血管外科杂志, 2019, 35(3):187-189.
[28] 柳常青, 吴汉然, 郭明发, 等.改良充气式纵隔镜在早期胸段食管癌中的临床应用[J]. 中华胸心血管外科杂志, 2019, 35(2):80-85.
[29] van ROSSUM, PETER S N, MOHAMMAD N H, et al. Treatment for unresectableor metastatic oesophageal cancer:current evidence and trends[J]. NatRev Gastroenterol Hepatol, 2018, 15(4):235-249.
[30] GRIMMINGER P, HADZIJUSUFOVIC E, LANG H.Robotic-Assisted Ivor Lewis Esophagectomy(RAMIE) with a standardized intrathoracic circular end-to-side stapled anastomosis and a team of two(surgeon and assistant only)[J]. Thorac Cardiovasc Surg, 2018, 66(5):404-406.
[31] SARKARIA I S, RIZK N P, GOLDMAN D A, et al. Early quality of life outcomes after robotic-assisted minimally invasive and open esophagectomy[J]. Ann Surg Oncol, 2019, 108(3):920-928.
[32] LOW D E, KUPPUSAMY M K, ALDERSON D, et al. Benchmarking complications associated with esophagectomy[J]. Ann Surg, 2019, 269(2):291-298.
[33] CHAO Y K, HSIEH M J, LIU Y H, et al. Lymph node evaluation in robot-assisted versus video-assisted thoracoscopic esophagectomy for esophageal squamous cell carcinoma:a propensity-matched analysis[J]. World J Surg, 2018, 42(2):590-598.
[34] ZHANG Y, HAN Y, GAN Q, et al. Early outcomes of robot-assisted versus thoracoscopic assisted Ivor Lewis esophagectomy for esophageal cancer:a propensity score-matched study[J]. Ann Surg Oncol, 2019, 26(5):1284-1291. |
